pngvl4acrte6e7l2
Vaccineexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jun 30, 2019 (NCT03913117)
Timeline
2010s
- Jan 1, 2019
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Human papillomavirus - 16Immunity, active
Human papillomavirus - 16 immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04131413 | Phase 1 | Dec 31, 2019 | Johns Hopkins University, National Cancer Institute (NCI) |
| NCT03913117 | Phase 1 | Jun 30, 2019 | Johns Hopkins University, University of Alabama, Birmingham |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Johns Hopkins University | Academic/Hospital | 2 | 1 | 1 | 2019 |
| National Cancer Institute (NCI) | Government | 1 | 0 | 1 | 2019 |
| University of Alabama, Birmingham | Academic/Hospital | 1 | 1 | 1 | 2019 |
3 organizations
Page 1 / 1